Biotech firm Kailos Genetics gets backing from IC venture arm In-Q-Tel
By
Ross Wilkers
Biotechnology company Kailos Genetics gets backing from the intelligence community's investment arm In-Q-Tel for a new sequencing laboratory.
Biotechnology firm Kailos Genetics has received an investment from the intelligence community investment arm In-Q-Tel to help further develop a new genetic sequencing laboratory.
Terms of the partnership were not disclosed. IQT seeks to further spur efforts on both the laboratory and cloud-based software used to perform genetic sequencing.
Huntsville, Ala.-based Kailos started in 2010 to advance genetic testing for partners such as hospitals, physicians, laboratories and pharmacies. Kailos' portfolio includes a laboratory information system built to manage samples in a lab environment, perform analytics and give users reports.
Founded in 1999, IQT seeks to identify startup companies whose technologies have potential use in the intelligence community.